Back to Search
Start Over
Amivantamab/Chemotherapy Prolongs Progression-Free Survival in NSCLC.
- Source :
- Targeted Therapies in Oncology; Jun2024, Vol. 13 Issue 7, p47-48, 2p
- Publication Year :
- 2024
- Subjects :
- THERAPEUTIC use of antineoplastic agents
THERAPEUTIC use of monoclonal antibodies
COMBINATION drug therapy
PROTEIN-tyrosine kinase inhibitors
CONFERENCES & conventions
PATIENT care
CANCER chemotherapy
LUNG cancer
PROGRESSION-free survival
GENETIC mutation
EPIDERMAL growth factor receptors
DISEASE progression
OVERALL survival
Subjects
Details
- Language :
- English
- ISSN :
- 15398226
- Volume :
- 13
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Targeted Therapies in Oncology
- Publication Type :
- Periodical
- Accession number :
- 177975530